Statement Of Cash Flows [Abstract]

Onward Medical N.V. - Filing #5877475

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2022-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Profit (loss)
35,725,000 EUR
EUR
EUR
EUR
35,725,000 EUR
EUR
36,181,000 EUR
EUR
36,181,000 EUR
EUR
Adjustments to reconcile profit (loss) [abstract]
Adjustments for share-based payments
2,720,000 EUR
2,564,000 EUR
Other adjustments for non-cash items
143,000 EUR
197,000 EUR
Interest paid, classified as operating activities
1,742,000 EUR
EUR
Interest received, classified as operating activities
686,000 EUR
916,000 EUR
Cash flows from (used in) operating activities
31,763,000 EUR
32,270,000 EUR
Cash flows from (used in) investing activities [abstract]
Purchase of property, plant and equipment, classified as investing activities
150,000 EUR
422,000 EUR
Purchase of intangible assets, classified as investing activities
EUR
EUR
Cash flows from (used in) investing activities
150,000 EUR
19,578,000 EUR
Cash flows from (used in) financing activities [abstract]
Proceeds from issuing shares
70,000,000 EUR
EUR
Proceeds from borrowings, classified as financing activities
14,116,000 EUR
1,292,000 EUR
Repayments of borrowings, classified as financing activities
15,255,000 EUR
EUR
Payments of lease liabilities, classified as financing activities
560,000 EUR
479,000 EUR
Cash flows from (used in) financing activities
62,560,000 EUR
813,000 EUR
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
30,647,000 EUR
11,879,000 EUR
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
372,000 EUR
113,000 EUR
Cash and cash equivalents
60,043,000 EUR
29,768,000 EUR
41,760,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.